COMI:EGXCommercial International Bank - Egypt (CIB) S.A.E. Analysis
Data as of 2026-06-19 - not real-time
SEK 3.42
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Comintelli AB is trading above its short‑term moving averages, indicating a bullish price bias, yet the MACD histogram remains in bearish territory and the RSI sits in a neutral zone, suggesting limited upside momentum. Volume is on the rise, supporting the short‑term trend, but the stock is priced well above the discounted cash flow estimate, signaling a clear overvaluation. The company’s revenue has contracted and margins are deeply negative, with operating and profit margins both in the red, underscoring ongoing profitability challenges. Despite a modest cash cushion and zero debt, operating cash flow is negative, though free cash flow turned slightly positive, hinting at a fragile cash conversion profile. The sector—technology software—carries medium inherent risk, while the low beta points to limited systematic market exposure, though the recent price swings reflect high short‑term volatility. Geographic exposure to Sweden adds a medium level of regional risk, and trading in SEK introduces a medium currency risk for EGX investors. Liquidity is constrained by a small market cap and modest average volumes, raising concerns about trade execution in larger positions. Overall, the combination of technical resistance, weak fundamentals, and an inflated market price suggests caution. Investors should weigh the bullish technical backdrop against the fundamental headwinds before taking action.
Given these dynamics, the stock may experience short‑term pressure if sentiment shifts, while any medium‑term recovery would likely depend on successful product roll‑outs and improved cash generation. Long‑term prospects remain uncertain without a clear path to profitability, making the current valuation difficult to justify.
Given these dynamics, the stock may experience short‑term pressure if sentiment shifts, while any medium‑term recovery would likely depend on successful product roll‑outs and improved cash generation. Long‑term prospects remain uncertain without a clear path to profitability, making the current valuation difficult to justify.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- bearish MACD histogram
- price trading near resistance with limited upside
- high short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- positive free cash flow offset by negative operating cash flow
- zero debt provides balance sheet flexibility
- need for meaningful revenue growth to justify valuation
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- persistent negative earnings and margins
- stock price far above DCF fair value
- uncertain path to sustainable profitability
Key Metrics & Analysis
Financial Health
Revenue Growth-8.40%
Profit Margin-14.72%
ROE-36.34%
ROA-9.03%
P/B Ratio3.4
Op. Cash FlowSEK-3021197
Free Cash FlowSEK194.3K
Industry P/E38.1
Technical Analysis
TrendBullish
RSI44.8
SupportSEK 3.34
ResistanceSEK 3.58
MA 20SEK 3.49
MA 50SEK 3.45
MA 200SEK 3.04
MACDBearish
VolumeIncreasing
Fear & Greed Index91.11
Valuation
Fair ValueSEK 0.57
GradeOvervalued
TypeValue
Risk Assessment
Beta0.06
Volatility32.67%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.